Back

Which patients with CAD or PAD are at the highest risk of cardiovascular events... What do the registries teach us.

29 August 2017 (12:50 - 13:15)
Organised by:
Congress Presentation Part of: Exploring vascular protection in patients with coronary artery disease (CAD) or peripheral artery disease (PAD) through the potential of factor Xa inhibition... The COMPASS study Thrombosis and coagulation Open Access ESC Congress 2017

About the speakers

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

Photo
Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

3 More presentations in this session

Presentation thumbnail
Opening remarks - Exploring vascular protection in patients with CAD or PAD through the potential of factor Xa inhibition... The COMPASS study.
Doctor S. Yusuf (Hamilton, CA)
Slides Video
Presentation thumbnail
The COMPASS study... Vascular protection with rivaroxaban in patients with CAD or PAD.
Doctor S. Connolly (Hamilton, CA) Doctor J. Eikelboom (Hamilton, CA)
Slides Video
Presentation thumbnail
Closing remarks - Exploring vascular protection in patients with CAD or PAD through the potential of factor Xa inhibition... The COMPASS study.
Doctor S. Connolly (Hamilton, CA)
Slides

Access the full session

Session thumbnail
Exploring vascular protection in patients with coronary artery disease (CAD) or peripheral artery disease (PAD) through the potential of factor Xa inhibition... The COMPASS study

The Event

Event poster

ESC Congress 2017

29 August 2017 12:50 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources